• EATRIS - European Infrastructure for Translational Medicine
• ECRIN - European Clinical Research Infrastructure Network

• Conect4children (c4c) -  Collaborative network for European clinical trials for children (777389)
  Dra. Ana Morales Tirado
• i-ABC - Inhaled antibiotics in bronchiectasias and cystic fibrosis (115721)
  Dr. Rafael Cantón
• COMBACTE-CARE - Combatting bacterial resistence in EuropeCarbapenem Resistence (115620)
  Dr. Rafael Cantón
• COMBACTE-NET - (Combatting Bacterial Resistance in Europe): ARTHR-IS study: Retrospective study to identify the incidence, risk factors and outcomes of prosthetic joint infection due to Staphylococcus aureus after primary knee or hip joint replacement", con código FIS-MET-2019-01.
  Dr. Francisco J. Cobo Reinoso.
• SPRINTT - Sarcopenia and physical frailty in older people: multi-component treatment strategies (115621-3)
  Dr. Alfonso J. Cruz-Jentoft
• ENABLE - European Gram Negative Antibacterial Engine (115583)
  Dr. Fernando Baquero
• 3TR - Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory and Allergic Conditions (831434).
  Dra. Luisa María Villar
• CARDIATEAM - CARdiomyopathy in type 2 DIAbetes mellitus (821508)
  Dr. José Luis Zamorano

• MON4STRAT - Therapeutic Beta-Lactams Monitoring for Stratified and dose adjusted treatment of hospital-acquired pneumonia: improved efficacy, decreased treatment length, and reduction of emergence of resistance (602906-2)
  Dr. Rafael Cantón
• SENATOR - Development and clinical trials of a new Software ENgine for the Assessment & Optimization of drug and nondrug Therapy in Older peRsons (305930)
  Dr. Alfonso José Cruz-Jentoft

• RETENTION - heaRt failurE paTient managEment and iNTerventIOns usiNg continuous patient monitoring outside hospitals and real world data (965343)
  Dr. José Luis Zamorano
• RESILIENCE. - Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines (945118).
  Dr. Javier López Jiménez
• VISION - Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSIs of gastrOintestinal caNcers (857381)
  Dr. Alfredo Carrato
• CARBALIVE - Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease (634579)
  Dr. Agustín Albillos
• MyCyFAPP - Innovative approach for self-management and social welfare of cystic fi brosis patients in Europe: development, validation and implementation of a telematics tool (643806)
  Dra. María Garriga
• ImmunAID - Immunome project consortium for AutoInflammatory Disorders (779295)
  Dra. Alina Lucica Boteanu
• FAST-Bact - A novel fast and automated kit for antibiotic susceptibility testing for Gram positive and negative bacteria (730713)
  Dr. Rafael Cantón
• Colodetect - Development of a novel bloodbased diagnostic test for colorectal cancer.
  Dr. Fernando Liaño García
• BADGER - CalScreener® - an innovative device for bacterial analysis and diagnostics through growth and energy-release in real-time (784514)
  Dr. Rafael Cantón Moreno
• NanoTBTech - Nanoparticles-based 2D thermal bioimaging technologies (801305)
  Dr. Daniel Jaque Garcia
• EATRIS-Plus - Consolidating the capacities of EATRIS-ERIC for Personalised Medicine (871096)
  Dra. Laura García Bermejo
• DECISION - Decompensated cirrhosis: identification of new combinatorial therapies based on system approaches (847949)
  Dr. Agustín Albillos

• REPLAY (MSCA-IF) - Analysing the role of history, chance and selection on the evolution of plasmid-mediated antibiotic resistance (895671).
  Dr. Alfonso Santos
• PurinesDX (MSCA-ITN) - Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases (766124)
  Dr. José Luis López-Sendón

• BioPac - Biomarkers of tumor recurrence in pancreatic cancer
  Dr. Alfredo Carrato
• SCRAtCH - Microbiota-based screening of anal cancer in HIV-infected individuals
  Dr. Sergio Serrano Villar
• NExT - Establishing an algorithm for the early diagnosis and follow-up of patients with pancreatic neuroendocrine tumors.
  Dr. Alfredo Carrato

• European upconversion network. - The European upconversion network - from the design of photon-upconverting nanomaterials to biomedical applications (CM1403).
  Dr. Daniel Jaque
• Nano2Clinic - Cancer Nanomedicine – from the bench to the bedside (CA17140)  
  Dr. Daniel Jaque
• CliniMARK - Good biomarker practice (CA16113)
  Dra. Laura García Bermejo
• TRANSAUTOPHAGY - European Network for Multidisciplinary Research on Autophagy (CA15138)
  Dr. José Antonio Rodríguez Navarro
• ENIUS - European network of multidisciplinary research to improve the urinary stents (CA16217)
  Dr. Javier Burgos y Dra. Victoria Gómez Dos Santos

• STARCS - Selection and Transmission of Antimicrobial Resistance in Complex Systems.
  Dra. Teresa Coque
• TRANSMISSION - Escherichia coli ST131: a model for high-risk.
  Dr. Fernando Baquero
• NEAR-AMR - Network of European and African Researchers on Antimicrobial Resistance.
  Dra. María Teresa Coque
• SOLIDNESS - Surveillance Of mobiLome meDiated aNtibiotic rEsiStance Spread.
  Dra. María Teresa Coque

• PLASREVOLUTION - Understanding the evolution of plasmid-mediated antibiotic resistance in real life scenarios (757440)

• HF-PREDICT - A Clinical Wearable System with Predictive Analytics for Heart Failure Managements
  Dr. José Luis Zamorano

• PREDIRA - Prediction medical device for rheumatoid arthritis (19577)
  Dra. Mónica Vázquez
• CHRONIC PAIN - Electrical quantitative sensory assessment system for failed back surgery syndrome
  Dr. José Luis de la Calle

• MICROCARE study (within COMBACTE-NET) - A multicenter, randomized, placebo-controlled, parallel-arm clinical trial to evaluate the efficacy of DAV132 in preventing Clostridioides difficile infection in patients with newly diagnosed Acute Myeloid Leukemia or high-risk Myelodysplastic Syndrome treated with intensive chemotherapy.
  Dr. Francisco Javier Cobo
• cASPerCF study (within Conect4children (c4c)) - Prospective validation and clinical evaluation of a new posaconazole dosing regimen for children and adolescents with cystic fibrosis and Aspergillus infection, cASPerCF_2007_OPBG_2019.
  Dra. Ana Morales Tirado
• EURECA - Study (within COMBACTE CARE): European prospective cohort study on Enterobacteriaceae showing resistance to carbapenems (NCT02709408)
  Dr. Vicente Pintado
• ANTICIPATE - study (within COMBACTE NET): Assessment of the incidence of Clostridium difficile infections in hospitalized patients on antibiotic treatment (UMC-FLU-2016-01).
  Dr. Francisco Javier Cobo
• ARTHR-IS - study (within COMBACTE NET): Retrospective study to identify the incidence, risk factors and outcomes of prosthetic joint infection due to Staphylococcus aureus after primary knee or hip joint replacement", con código FIS-MET-2019-01.
  Dr. Francisco Javier Cobo
• REVISIT - study (within COMBACTE CARE): A Phase 3 prospective, randomized, multicenter, open label, central assessor blinded, parallel group, comparative study to determine the efficacy, safety and tolerability of aztreonam avibactam (ATM AVI) ±metronidazole (MTZ) versus meropenem±colistin (MER±COL) for the treatment of serious infections due to Gram negative bacteria, including metallo β lactamase (MBL) - producing multidrug resistant pathogens, for which there are limited or no treatment options.
  Dr. Francisco Javier Cobo